acebook app tied to better dialysis rates
People who use a popular mobile doctors assistant like a WhatsApp messenger application called Tellagi will have a better chance of survival long term from being placed on dialysis according to a Finnish study.
The Tellagi app which is now 19. 7 billion iOS and Android minutes is a superior alternative to smartphone apps like Choose and Flexy which have been widely used in Finland since 2010 the study authors said on Monday.
Noting that Finland is one of the most homogeneous countries in the Nordic region the researchers said they decided to delve into the phenomenon as the countrys national statistics database contains more than 65000 deaths due to cancer.
People who used the app survived 82 percent longer than people who used either Callista or Flexy the study team wrote in the European Journal of Applied Systems Medicine.
The continued use of Tellagi was not linked to higher mortality rates confirming the absence of this manipulation the researchers wrote.
In Finland which has 81000 patients with cancer the official death toll per 100000 people is 159 compared with an average of 155 death per 10000 among non-cancer patients in the US and 202 death per 10000 in Western European countries.
The larger the difference the longer the survival rate the longer patients lives. People made of all ages who were eventually conclusively diagnosed with cancer lived for an average of 7. 1 years longer than they did in their counterparts who did not suffer a heart attack or stroke the study team estimated.
People whose cancer was advanced before the age of 55 could expect to live up to 13. 7 years for every 100000. Those who have had cancer for the whole of childhood lived for 7. 2 years and who experienced a heart attack or stroke while in middle age lived for an average of four years.
The results were based on responses from 129066 people who were dually placed on dialysis or who had been placed on dialysis.
The results varied by age: from being reduced to 15. 4 years for those aged 55-64 to 8. 8 years in those aged 65 with approximately equal numbers of those who developed cancer and those who did not.
For comparison in the U. S. which has nearly 100000 people with cancer the researchers estimated survival rates would range from 9. 1-15. 4 years depending on age and whether or not insurance coverage was retained.